Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan:107:95-97.
doi: 10.1016/j.jhin.2020.11.009. Epub 2020 Nov 18.

ICU-acquired bloodstream infections in critically ill patients with COVID-19

Affiliations

ICU-acquired bloodstream infections in critically ill patients with COVID-19

S Kokkoris et al. J Hosp Infect. 2021 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Timeline for each individual patient with COVID-19 consecutively admitted to the intensive care unit (ICU) during the first pandemic wave. The case number reflects, for each patient, the date of ICU admission to date of death or discharge from the ICU. Red indicates the day of the first Bacteraemia; green indicates the day of Candidaemia, ×indicates the day of death. A polymicrobial population (one strain of Candida and one strain of Gram-negative bacterium) simultaneously grown by the same blood culture in one patient is shown with both colours.

References

    1. Garcia-Vidal C., Sanjuan G., Moreno-García E., Puerta-Alcalde P., Garcia-Pouton N., Chumbita M. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Ιnfect. 2020 doi: 10.1016/j.cmi.2020.07.041. - DOI - PMC - PubMed
    1. Soriano M.C., Vaquero C., Ortiz-Fernandez A., Caballero A., Blandino-Ortiz A., de Pablo R. Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19. J Infect. 2020 doi: 10.1016/j.jinf.2020.09.010. - DOI - PMC - PubMed
    1. Routsi C., Gkoufa A., Arvaniti K., Kokkoris S., Tourtoglou A., Theodorou V. De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. J Antimicrob Chemother. 2020;75:3665–3674. - PubMed
    1. Goyal P., Choi J.J., Pinheiro L.C., Schenck E.J., Chen R., Jabri A. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382:2372–2374. - PMC - PubMed
    1. Langford B.J., So M., Raybardhan S., Raybardhan S., Leung V., Westwood D. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infec. 2020 doi: 10.1016/j.cmi.2020.07.016. - DOI - PMC - PubMed